deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT04464408

Favipiravir Therapy in Adults With Mild COVID-19 (Avi-Mild)

A Trial of Favipiravir Therapy in Adults With Mild Coronavirus Disease COVID-19

Sponsor: King Abdullah International Medical Research Center

Conditions COVID-19
Interventions Favipiravir Placebo
Updated 10 times since 2020 Last updated: Nov 4, 2021 Started: Jul 23, 2020 Primary completion: Aug 4, 2021 Completion: Aug 4, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates COVID-19 and is currently completed. King Abdullah International Medical Research Center leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshotNot Yet Recruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshotRecruiting~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshotRecruiting~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshotCompleted~Nov 2025 – present · 8 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Nov 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2025 — Nov 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  5. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

    Status: Recruiting → Completed

▶ Show 5 earlier versions

  1. Apr 2021 — Dec 2021 [monthly]

    Recruiting PHASE2_PHASE3

  2. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE2_PHASE3

  3. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2_PHASE3

  4. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

  5. Aug 2020 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • King Abdullah International Medical Research Center
  • Ministry of Health, Saudi Arabia
Data source: King Abdullah International Medical Research Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations